Clonidine Versus Captopril for Treatment of Postpartum Very High Blood Pressure
NCT01761916 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2013-07-29
Summary
The postpartum period represents a stage of the pregnancy-puerperal still rarely addressed scientifically. There are no reports in the literature and concrete enough to elucidate important issues, especially in the field of hypertension and pregnancy.
Searches based on current evidence concentrate their focus on the diagnosis of hypertensive disorders and treatment of these diseases maternofetais repercussions. However, the prognosis in the short and long term, as the BP outcome in mothers with severe preeclampsia, the most effective treatment for the control of hypertensive crisis and metabolic and cardiovascular events after two years of termination of pregnancy require further clarification.
The main idea for developing this research came from the clinical experience with the use of captopril in Obstetric ICU IMIP. This drug has long been used in postpartum women with severe preeclampsia or chronic hypertension exacerbated by pregnancy for control of hypertensive crisis and keeping pressure levels. Following the technical standards of the institution and during his administration, there were reports of side effects such as dry cough and nausea, beyond the threshold dose of 150mg daily captopril was easily achieved hindering control the use of hypotensive.
Alternative therapy, clonidine began to be used in mothers with some restriction on the use of ACE inhibitors and its hypotensive effect for peak pressure was satisfactory. What is not known yet is how long clonidine reduces high blood pressure and how long to leave stabilized compared to the use of captopril.
There are no reports in the literature databases, no randomized clinical trials that prove the effectiveness of clonidine for the treatment of hypotensive pressure peaks in this particular group of patients, even in comparison with other classes of antihypertensive drugs, especially captopril, to this purpose.
The investigators' primary assumption is that clonidine has better effectiveness in decreasing the frequency of pressure peaks when compared with captopril.
Conditions
Interventions
- DRUG
-
CLONIDINE
Postpartum patients with very high blood pressure will be treated with oral clonidine (0,1mg)
- DRUG
-
CAPTOPRIL
Postpartum patients with very high blood pressure will be treated with oral captopril (25mg)
Sponsors & Collaborators
-
Instituto Materno Infantil Prof. Fernando Figueira
lead OTHER
Principal Investigators
-
Carlos Noronha, MD · IMIP
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2013-06-30
- Completion
- 2013-06-30
Countries
- Brazil
Study Locations
More Related Trials
-
Innovation in Postpartum Care for Women With Hypertensive Disorders of Pregnancy
NCT03613714 ·Status: COMPLETED ·Phase: NA
-
Amlodipine Versus Nifedipine ER for the Management of Postpartum Hypertension
NCT04790279 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Severe Postpartum Hypertension
NCT02450773 ·Status: WITHDRAWN ·Phase: PHASE2
-
Comparing Nifedipine and Enalapril in Medical Resources Used in the Postpartum Period
NCT04236258 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Nifedipine Versus Labetalol in Treatment of Postpartum Hypertension
NCT03449277 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of Tab.Labetalol and Tab.Nifedipine for Management of Postpartum Hypertension
NCT02426177 ·Status: UNKNOWN ·Phase: PHASE3
-
Understanding Blood Pressure Changes After Birth
NCT05137808 ·Status: UNKNOWN
-
Treatment Targets for Chronic Hypertension in Pregnancy
NCT00194974 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Postpartum Evaluation of Nifedipine and Enalapril for Hypertension
NCT07023003 ·Status: RECRUITING ·Phase: PHASE4
-
A Comparison of Compliance Between Clonidine Patch and Methyldopa for the Treatment of Chronic Hypertension in Pregnancy
NCT00329511 ·Status: WITHDRAWN ·Phase: NA
-
Persistent Postpartum Hypertension Pilot Trial
NCT04349124 ·Status: TERMINATED ·Phase: PHASE4
-
Oral Combined Hydrochlorothiazide/Lisinopril Versus Oral Nifedipine for Postpartum Hypertension
NCT05049616 ·Status: COMPLETED ·Phase: PHASE4
-
Inorganic Nitrate Supplementation in Chronic Hypertensive Pregnancies
NCT06105775 ·Status: RECRUITING ·Phase: NA
-
Preeclampsia Postpartum Antihypertensive Treatment
NCT04298034 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy of Diltiazem for the Control of Blood Pressure in Puerperal Patients With Severe Preeclampsia
NCT04222855 ·Status: COMPLETED ·Phase: NA
-
Response to Anti-hypertensives in Pregnant and Postpartum Patients
NCT03506724 ·Status: COMPLETED ·Phase: PHASE4
-
Hypertension Explored in Long-term Postpartum Follow-up in Later Life
NCT06187012 ·Status: RECRUITING
-
Lisinopril for Renal Protection in Postpartum Preeclamptic Women
NCT05016440 ·Status: WITHDRAWN ·Phase: NA
-
Oral Antihypertensive Regimens for Management of Hypertension in Pregnancy
NCT01912677 ·Status: COMPLETED ·Phase: PHASE4
-
Furosemide for Accelerated Recovery of Blood Pressure Postpartum
NCT03556761 ·Status: COMPLETED ·Phase: PHASE2
-
Safest Choice of Antihypertensive Regimen for Postpartum Hypertension
NCT05551104 ·Status: RECRUITING ·Phase: PHASE3
-
Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide
NCT03298802 ·Status: RECRUITING ·Phase: PHASE3
-
Anti-Hypertensive Treatment In Stable Pregnant Women With Severe Pre-Eclampsia (Metildopape)
NCT01361425 ·Status: UNKNOWN ·Phase: PHASE4
-
Progesterone in Expectantly Managed Early-onset Preeclampsia
NCT04077853 ·Status: COMPLETED ·Phase: PHASE4
-
Ambulatory Blood Pressure and the Normal Increase in Maternal Blood Pressure Postpartum
NCT02912403 ·Status: WITHDRAWN